Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis. (Q41561248)
Jump to navigation
Jump to search
scientific article published on 4 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis. |
scientific article published on 4 January 2015 |
Statements
Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis (English)
Proteus mirabilis
1 reference
Escherichia coli
1 reference
Mehri Habibi
Mohammad Reza Asadi Karam
4 January 2015